Biological agents and tuberculosis: risk estimates and screening strategies.
Liverpool Hospital, South Western Sydney Clinical School, UNSW Australi, Sydney, New South Wales, Australia; Woolcock Institute of Medical Research, Sydney, New South Wales, Australia. c.dobler@unsw.edu.au.
Claudia C
CC
Dobler
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D059425:Interferon-gamma Release Tests; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000453:epidemiology*; D008297:Male; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014374:Tuberculin Test; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha